Isoenzyme specific PFK-2/FBPas-2 inhibition as an anti-cancer strategy
<p>High aerobic glycolytic capacity is correlated with poor prognosis and increased tumour aggressiveness. 6Phosphofructo-1-kinase catalyses the first irreversible step of glycolysis, and is activated by fructose-2,6-bisphosphate, a product of the kinase activity of four bifunctional isoenzyme...
Príomhchruthaitheoir: | Williams, J |
---|---|
Rannpháirtithe: | Harris, A |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
2013
|
Ábhair: |
Míreanna comhchosúla
-
Isoenzyme-specific PFK-2/FBPase-2 Inhibition as an Anti-cancer Strategy
de réir: Williams, J, et al.
Foilsithe / Cruthaithe: (2012) -
Design, synthesis and biological evaluation of glycosidase inhibitors in an anti-cancer setting
de réir: Glawar, AFG
Foilsithe / Cruthaithe: (2013) -
The synthesis and biological evaluation of novel N-acetylhexosaminidase inhibitors
de réir: Crabtree, E, et al.
Foilsithe / Cruthaithe: (2011) -
Functional and inhibition studies on 2-oxoglutarate-dependent oxygenases
de réir: Thalhammer, A
Foilsithe / Cruthaithe: (2012) -
New methods for nucleophilic fluorination
de réir: Cresswell, A
Foilsithe / Cruthaithe: (2011)